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Coronary artery disease is a serious complication of chronic
kidney disease (CKD); however, there is little information
about coronary plaque morphology in these patients. Here
we identified the characteristics of coronary culprit plaques
and their clinical manifestations in 78 patients with CKD
divided into four groups based on their estimated glomerular
filtration rate. Patients were examined by Virtual Histology-
Intravascular Ultrasound, a tomographic imaging method
that can visualize atherosclerotic plaques in vivo using
radiofrequency analysis of ultrasound backscatter signals.
These ultrasound analyses showed an increase in the relative
volumes of both dense calcium and necrotic core with
decreasing renal function. The necrotic core/dense calcium
ratio was significantly higher in patients with acute
myocardial infarction compared to those with stable angina
pectoris. Furthermore, the necrotic core/dense calcium ratio
decreased in advanced CKD. Thus, the plaque composition of
coronary culprit lesions changed from necrotic core-rich to
extensively calcium-rich plaques as renal function decreased,
suggesting that such coronary culprit composition was
associated with stability, particularly in advanced CKD.
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Cardiovascular disease (CVD) is the leading cause of mortality
in patients with chronic kidney disease (CKD).1 It has been
reported that these patients have more severe atherosclerotic
lesions in coronary plaques as renal function decreases.2,3
However, only a few studies have assessed coronary plaque
composition in autopsy subjects. Although there are several
imaging devices for the detection of coronary plaques, such as
electron beam computed tomography, multidetector com-
puted tomography, and magnetic resonance imaging, these
devices provide only limited data about plaque morphology.
Virtual Histology-Intravascular Ultrasound (VH-IVUS)
is a new tomographic imaging device that can visualize
atherosclerotic plaques in vivo using radiofrequency analysis
of ultrasound backscatter signals.4 VH-IVUS can provide
detailed information regarding the four major plaque
components, and accuracy has been confirmed by compar-
ison with histopathological findings (87.1% for fibrous,
87.1% for fibro fatty, 88.3% for necrotic core, and 96.5% for
dense calcium).5 This device is prevalently used not only in
the decision-making process for coronary intervention in
clinical settings but also in the assessment of coronary plaque
morphology in clinical trials. There are accumulated
evidences about the characteristics of coronary plaque
composition and plaque stability using this imaging modal-
ity.5–10 Our previous study demonstrated that hemodialysis
(HD) patients had greater volumes of dense calcium and
necrotic core on VH-IVUS analysis compared with control
patients.11 However, there are no studies providing detailed
analysis of coronary culprit plaques in living patients with
various degrees of renal function.
The objective of this study was to identify coronary culprit
plaque characteristics using VH-IVUS analysis in patients
with CKD, including HD patients.
RESULTS
Patient characteristics
Table 1 compares patient characteristics among the four
groups. Age, body mass index, smoking, and the presence
of diabetes and hyperlipidemia were comparable among the
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four groups. Hypertension was more prevalent in the esti-
mated glomerular filtration rate (eGFR) o30ml/min per
1.73m2 and HD groups compared with the eGFRX60ml/min
per 1.73m2 group. Serum hemoglobin levels were significantly
lower in the HD group compared with the eGFRX60ml/min
per 1.73m2 and 30p eGFR o60ml/min per 1.73m2 groups.
Serum phosphate levels and calcium–phosphorus products
were significantly higher in the eGFRo30ml/min per 1.73m2
and HD groups compared with the eGFR X60ml/min per
1.73m2 and 30p eGFR o60ml/min per 1.73m2 groups.
Coronary angiography findings
Table 2 demonstrates the coronary angiography findings. The
location of culprit lesions was similar among the four groups.
Multivessel disease was more frequent, and single vessel
disease was less frequent in the HD group compared with the
other groups.
Coronary culprit plaque morphology by VH-IVUS analysis
As demonstrated in Table 3, the volumes of both total plaque
and vessel did not significantly differ among the four groups.
With regard to coronary plaque composition, the relative
volumes of dense calcium (%DC) and necrotic core (%NC)
gradually increased with decreasing renal function (Figure 1).
Table 1 | Patient characteristics
eGFR (ml/min per 1.73m2)
Variables X60 (n=31) 30–60 (n=24) o30 (n=11) HD (n=12) P-value
Estimated GFR (ml/min per 1.73m2) 80.7±15.4 47.1±7.8b 20.9±8.7b,d — o0.001
Age (years) 66±11 70±10 67±13 65±8 0.507
Sex (male; n, %) 15 (48) 21 (88)b 8 (73) 3 (25) o0.005
Body mass index (kg/m2) 23.7±4.8 23.7±2.9 26.5±5.1 23.8±3.8 0.242
Comorbidities (n, %)
Smoking 10 (32) 7 (29) 2 (18) 4 (33) 0.831
Diabetes 15 (48) 9 (38) 7 (64) 9 (75) 0.151
Hypertension 17 (55) 18 (75) 10 (91)a 12 (100)b o0.01
Hyperlipidemia 21 (68) 11 (46) 7 (64) 5 (42) 0.261
Diagnosis (n, %)
Myocardial infarction 13 (42) 10 (42) 3 (28) 1 (8) o0.01
Unstable angina pectoris 12 (39) 5 (21) 4 (36) 10 (84)a,c
Stable angina pectoris 6 (19) 9 (37) 4 (36) 1 (8)
Laboratory data
Hemoglobin (g/dl) 12.7±2.3 12.7±1.8 11.4±2.6 10.0±1.9b,d o0.005
Serum albumin (mg/dl) 3.7±0.5 3.5±0.5 3.2±0.4a 3.4±0.5 o0.01
LDL cholesterol (mg/dl) 110.1±34.2 102.8±27.1 115.4±42.1 99.5±39.0 0.662
HDL cholesterol (mg/dl) 43.2±10.5 40.8±11.6 44.3±12.8 40.3±14.1 0.765
Triglycerides (mg/dl) 152.1±130.9 115.6±52.2 133.8±39.6 170.1±119.3 0.431
Hemoglobin A1c (%) 6.3±1.3 6.1±1.3 6.3±1.0 5.8±1.1 0.584
C-reactive protein (mg/dl) 1.0±2.0 1.3±2.2 1.6±1.6 2.5±3.6 0.314
Serum calcium (mg/dl) 9.0±0.5 8.6±0.7a 8.6±0.6 8.7±0.5 o0.05
Serum phosphate (mg/dl) 3.3±0.5 3.2±0.6 4.0±0.7a,c 4.8±0.9b,d o0.001
Calcium–phosphorus products (mg2/dl2) 30.5±5.9 29.3±6.6 38.0±7.0a,c 44.5±8.4b,d o0.001
Intact-PTH (pg/ml) — — — 271.3±140.4 —
Medications (n, %)
Phosphate binders 0 (0) 0 (0) 0 (0) 8 (67)b,d,f o0.001
Calcium-containing — — — 8
Sevelamer hydrochloride — — — 1
Vitamin D 0 (0) 0 (0) 0 (0) 7 (58)a,c,e o0.001
Renin–angiotensin system blocker 13 (42) 16 (67) 7 (64) 8 (67) 0.220
Statin 17 (55) 14 (58) 6 (55) 4 (33) 0.536
Abbreviations: eGFR, estimated glomerular filtration rate; HD, hemodialysis; HDL, high-density lipoprotein; LDL, low-density lipoprotein; PTH, parathyroid hormone.
Vs. eGFR X60: aPo0.05, bPo0.01. Vs. 30p eGFRo60: cPo0.05, dPo0.01. Vs. eGFR o30: ePo0.05, fPo0.01.
Table 2 | Coronary angiography findings
eGFR (ml/min per 1.73m2)
X60
(n=31)
30–60
(n=24)
o30
(n=11)
HD
(n=12) P-value
Culprit lesion
LAD (%) 13 (42) 10 (42) 4 (36) 5 (42) 0.812
LCX (%) 5 (16) 5 (20) 1 (9) 3 (25)
RCA (%) 13 (42) 9 (38) 6 (55) 4 (33)
Proximal (%) 25 (81) 19 (79) 9 (82) 9 (75) 0.556
Distal (%) 6 (19) 5 (21) 2 (18) 3 (25)
Number of diseased vessels
Single (%) 15 (48) 5 (21) 6 (55) 1 (8)a o0.05
Double (%) 9 (29) 13 (54) 2 (18) 3 (25)
Triple (%) 7 (23) 6 (25) 3 (27) 8 (67)
Abbreviations: eGFR, estimated glomerular filtration rate; HD, hemodialysis; LAD, left
anterior descending coronary artery; LCX, left circumflex coronary artery; RCA, right
coronary artery.
Vs. eGFR X60ml/min per 1.73m2: aPo0.05.
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%DC was significantly higher in the eGFR o30ml/min
per 1.73m2 and HD groups compared with the eGFR
X60ml/min per 1.73m2 group (Po0.05). The NC/DC ratio,
which was defined as %NC/%DC for assessment of plaque
transformation, gradually decreased with the development
of CKD (Figure 2).
Coronary plaque composition and risk factors
%NC was significantly and positively correlated with the
presence of diabetes mellitus (r¼ 0.432, Po0.001), hemo-
globin A1c (HbA1c; r¼ 0.383, Po0.01), serum phosphate
levels (r¼ 0.234, Po0.05), and calcium–phosphorus pro-
ducts (r¼ 0.253, Po0.05), whereas %NC was significantly
and negatively correlated with eGFR (r¼0.280, Po0.05).
%DC was significantly and positively correlated with the
presence of diabetes mellitus (r¼ 0.284, Po0.05) and
hypertension (r¼ 0.247, Po0.05), serum phosphate levels
(r¼ 0.464, Po0.0001), and C-reactive protein (r¼ 0.254,
Po0.05), whereas %DC was significantly and negatively
correlated with eGFR (r¼0.454, Po0.001). In addition,
%DC tended to be correlated with serum albumin levels
(r¼0.218, P¼ 0.06) and HbA1c (r¼ 0.217, P¼ 0.06). In
the multivariate analysis, the presence of diabetes mellitus
and eGFR were significantly correlated with the extent of
coronary plaque calcification (Table 4).
Coronary culprit plaque morphology and types of
coronary artery disease
The NC/DC ratio was significantly higher in patients with
acute myocardial infarction (AMI) than in those with stable
angina pectoris (SAP; Figure 3). When patients were divided
into two groups according to acute coronary syndrome
(ACS) and SAP, the ratio was significantly higher in patients
with ACS than in those with SAP (data not shown).
Furthermore, the NC/DC ratio was higher in patients with
AMI than in those with SAP even after stratification by renal
function (Figure 4). The maximal arc of the calcium deposit,
which indicates the size of clustered calcification in a
coronary culprit plaque, gradually increased with decreasing
renal function (Figure 5). Finally, total plaque volume was
significantly higher in patients with AMI and unstable angina
pectoris (UAP) than in those with SAP (AMI: 72.4±22.2,
UAP: 74.8±27.8, SAP: 56.0±15.9; Po0.05). The percentage
of plaque volume (% plaque volume) was also significantly
higher in patients with AMI and UAP than in those with SAP
(AMI: 69.3±8.8%, UAP: 69.9±6.9%, SAP: 61.8±8.7%;
Po0.05).
DISCUSSION
The results of this study demonstrated several important
findings, which are as follows: (1) the relative volumes of
both DC and NC gradually increased and the NC/DC ratio
gradually decreased in coronary culprit lesions with the
development of CKD; (2) the NC/DC ratio was significantly
higher in patients with AMI compared with those with SAP;
and (3) calcified lesions of coronary plaque gradually
developed in clusters as renal function decreased.
Table 3 | Gray-scale intravascular ultrasound measurement
eGFR (ml/min per 1.73m2)
X60 (n=31) 30–60 (n=24) o30 (n=11) HD (n=12) P-value
Vessel volume (mm3) 99.1±27.6 95.8±26.5 110.1±48.0 110.3±27.8 0.458
Lumen volume (mm3) 32.4±12.7 30.6±10.8 35.7±16.0 29.6±6.7 0.629
Plaque volume (mm3) 66.8±21.0 65.3±21.4 74.4±36.5 80.6±23.8 0.309
% Plaque volume (%) 66.8±8.7 67.2±9.5 66.3±8.8 73.1±4.7 0.247
Abbreviations: eGFR, estimated glomerular filtration rate; HD, hemodialysis.
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Figure 1 |Compositional pattern of coronary culprit lesions.
(a) Coronary plaque morphology of the culprit lesion. HD,
hemodialysis. Vs. eGFR (ml/min per 1.73m2) X60, *Po0.05.
Virtual Histology-Intravascular Ultrasound images of coronary
culprit plaque. eGFR (ml/min per 1.73m2) (b) X60, (c) 30–60, and
(d) o30, and (e) hemodialysis group. Green, fibrous; yellow, fibro
fatty; red, necrotic core; white, dense calcium. eGFR, estimated
glomerular filtration rate.
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There are many previous studies that have shown that
CKD patients have severe atherosclerosis and that they are at
high risk for CVD.2,3,12–14 However, only a few previous
studies have outlined the characteristics of coronary plaques
in detail. Two recent reports from autopsy subjects demon-
strated changes in coronary plaque morphology with
decreasing renal function.2,3 Nakamura et al.2 demonstrated
that coronary plaque calcification was more severe in patients
with CKD stages 3, 4–5, and 5D compared with those without
CKD. Nakano et al.3 also reported that atherosclerosis was
more advanced in patients with eGFR o45ml/min per
1.73m2 according to the classification by the Committee on
Vascular Lesions of the Council on Atherosclerosis, American
heart association. However, these autopsy studies were
considered to be limited particularly in terms of patient
selection. On the other hand, several imaging devices, such as
computed tomography and magnetic resonance imaging,
have been prevalently used for the assessment of coronary
artery disease (CAD) in living patients. However, detailed
analysis of coronary plaque composition cannot be per-
formed by computed tomography and magnetic resonance
imaging, even though the resolution of these noninvasive
imaging devices has improved. IVUS enables visualization
of the atherosclerotic plaque with high accuracy, and
Table 4 |Multivariate analysis between the relative volume of
dense calcium and clinical parameters
Variables b P-value
Age (years) 0.029 0.795
Diabetes (yes vs. no) 0.220 o0.05
Hypertension (yes vs. no) 0.088 0.427
eGFR (ml/min per 1.73m2) 0.308 o0.05
Serum albumin (mg/dl) 0.108 0.372
C-reactive protein (mg/dl) 0.220 0.062
Calcium–phosphorus products (mg2/dl2) 0.144 0.307
Abbreviation: eGFR, estimated glomerular filtration rate.
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Figure 3 |Comparison of necrotic core (NC)/dense calcium
(DC) ratio among different types of coronary artery disease
(CAD) in all the study patients. AMI, acute myocardial infarction;
SAP, stable angina pectoris; UAP, unstable angina pectoris. Vs.
SAP, *Po0.05.
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Figure 4 |Comparison of necrotic core (NC)/dense calcium
(DC) ratio among different types of coronary artery disease in
each group stratified by renal function. AMI, acute myocardial
infarction; eGFR, estimated glomerular filtration rate; HD,
hemodialysis; SAP, stable angina pectoris; UAP, unstable angina
pectoris.
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Figure 5 |Maximal arc of calcium deposit in the culprit lesion.
HD, hemodialysis. Vs. eGFR (ml/min per 1.73m2) X60: aPo0.05 vs.
30p eGFRo60: bPo0.05. eGFR, estimated glomerular filtration rate.
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Figure 2 |Necrotic core (NC)/dense calcium (DC) ratio in the
coronary culprit lesion. eGFR, estimated glomerular filtration
rate; HD, hemodialysis. Vs. eGRF (ml/min per 1.73m2) X60,
*Po0.05.
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provides information about coronary plaque morphology.5–11
Therefore, we used VH-IVUS to examine changes in
coronary culprit plaque morphology and their association
with clinical parameters in living CKD patients in this study.
In their study using VH-IVUS, Ogita et al.15 reported that
%NC and %DC in non-culprit coronary artery lesions
increased with decreasing renal function in diabetic CKD
patients. A recent study using Integrated Backscatter IVUS
demonstrated that coronary culprit plaques in patients with
eGFR o60ml/min per 1.73m2 included higher percentage
of lipid volume and lower percentage of fibrous volume
compared with those with an eGFR X60ml/min per
1.73m2. However, average renal function in the eGFR
o60ml/min per 1.73m2 group was 49±9ml/min per
1.73m2 in the study. Therefore, it seems that the lower eGFR
group mainly included CKD stage 3 patients.16 Thus, there
is relatively little data regarding coronary culprit plaque
morphology in living patients with various degrees of renal
function. In the present study, %NC and %DC in culprit
lesions of the coronary artery gradually increased with
decreasing renal function. Conversely, the NC/DC ratio
decreased with decreasing renal function. In addition, %NC
was significantly correlated with diabetes mellitus, eGFR, and
serum phosphorus levels. %DC was significantly correlated
with multiple risk factors, such as the presence of diabetes
mellitus and hypertension, eGFR, mineral disorders, and
inflammation. From these results, we speculated that NC and
calcified lesions in atherosclerotic plaques are induced in
patients with decreasing renal function not only by traditional
risk factors, such as diabetes and hypertension, but also by
nontraditional CKD-related risk factors, such as uremic toxins
and mineral disorders. Furthermore, it is suggested that the
decrease in the NC/DC ratio with reducing renal function
reflects plaque transformation from NC-rich plaques to
calcium-rich plaques.
Several studies have reported that vascular calcification is
markedly severe in CKD patients and the incidence of CVD
increases with decreasing renal function.17,18 It is well known
that the link between renal dysfunction and vascular
calcification is very important in cardio-renal association
and both are also crucial predictors of CVD.19,20 Interestingly,
US Renal Data System Data annual reports show that only
20% of deaths related to CVD in dialysis patients were caused
by myocardial infarction.21 Heart failure and arrhythmia
rather than AMI were frequently observed in advanced CKD
patients. Taking these facts into account, we postulated that
vascular calcification might be associated with a type of CVD
in CKD patients.
Pathological analysis of coronary plaques in the general
population demonstrated that ACS mainly resulted from
rupture of the vulnerable plaques, whereas calcified nodules
were least common. Such vulnerable plaques consisted of a
higher percentage of NC compared with stable plaques.22
Previous studies using VH-IVUS analysis also demonstrated
that a higher NC/DC ratio was associated with ACS.7,8
Although direct evidence regarding the relationship between
the NC/DC ratio and plaque stability may be absent, previous
studies have reported that NC decreases plaque stability,
whereas calcification increases its stability.7,8,22–24 In addition,
previous studies demonstrated an association between the
pattern of plaque calcification and plaque stability. Beckman
et al.9 reported that the maximal arc of the calcium deposits in
coronary culprit plaques was significantly lower in patients
with AMI compared with those with SAP. Using IVUS, Ehara
et al.10 also demonstrated that spotty calcification was most
frequent in AMI patients, whereas extensive calcification was
most frequent in SAP patients. Because the junction between
calcified and non-calcified lesions in atherosclerotic plaques is
thought to be weak against mechanical stress, the pattern of
calcium deposition may be an important indicator for plaque
stability.25
On the basis of the hypothesis that the NC/DC ratio and
the pattern of calcification in coronary artery plaques could
be indicators of plaque stability, we examined the association
of coronary plaque morphology with a type of CAD in CKD
patients. In this study, the NC/DC ratio was significantly
higher in patients with AMI compared with those with SAP,
and this tendency remained even after stratification by renal
function. In addition, the maximal arc of the calcium deposit
gradually increased with decreasing renal function. These
results indicate that the transformation from NC-rich
plaques into extensively calcium-rich plaques in coronary
culprit lesions may lead to plaque stability along with
declining renal function.
Previous studies have demonstrated that CKD patients
had coronary microvascular dysfunction despite the absence
of obstructive CAD.26,27 Furthermore, recent studies demon-
strated an association between impaired coronary micro-
vascular circulation and coronary artery calcification score in
HD patients.28,29 Coronary microvascular circulation reg-
ulates the balance between coronary blood flow supply and
myocardial demand, and its dysfunction could be assessed
by measuring coronary flow reserve in response to adenosine-
triphosphate stress. Our previous study demonstrated that
coronary flow reserve is positively and significantly associated
with renal function.27 In addition, reduced coronary flow
reserve is associated with the development of myocardial
ischemia and cardiovascular mortality.26,30 Although this was
not the focus of our study, coronary microvascular dysfunc-
tion, which is supposed to be associated with both decreasing
renal function and the increasing extent of coronary artery
calcification, may have an important role in the development
of cardiac abnormalities in CKD patients. In fact, heart
failure is the most frequent CVD in HD patients.31 Therefore,
we attributed the increased prevalence of CVD death, parti-
cularly in advanced CKD patients, to impairment of coronary
microvascular circulation related to vascular calcification.
Previous studies suggested that increased plaque burden
and lipid plaque volume were associated with the occurrence
of ACS.32,33 Results of this study showed that increased
plaque volume was associated with ACS; however, the
relationship between plaque volume and renal function
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could not be identified. Two autopsy studies demonstrated
that coronary plaque volume was comparable between CKD
patients and control patients, and there was no autopsy study
that investigated plaque volume in patients with varying renal
function.12,13 Furthermore, a previous study using VH-IVUS
analysis demonstrated that plaque volume was comparable
among patients with varying renal function.15 Rigatto et al.34
suggested that plaque growth may be driven not only by
impaired renal function but also by other factors, such as
hypertension and diabetes. Taking these facts into account,
the change in plaque volume remains controversial in CKD
patients, and longitudinal studies are needed to resolve this
issue. With regard to the association between hyperlipidemia
and CVD, randomized controlled trials of statin therapies in
HD patients, such as 4-D and AURORA trials, have failed to
show their effects on CVD outcomes.35,36 The present study
also could not identify a significant relationship between lipid
plaque volume and statin therapy (data not shown). These
results could be partly explained by the lipid metabolism
disorder specific to CKD patients. In fact, the present study
showed that serum low-density lipoprotein levels were lowest
in the HD group.
This study has some limitations. First, in the setting of the
study design inherence, this study could not establish a
cause–effect relationship. A longitudinal study is needed in
the future to resolve this issue. Second, the number of study
participants was relatively small, especially when patients
were divided into four groups according to the eGFR.
Certainly, if we were able to evaluate more patients, the
results would be more conclusive. Third, VH-IVUS was
performed for the decision-making process of coronary
intervention, and this study did not include the information
about coronary plaque other than the culprit lesion.
Furthermore, in general, it is difficult to analyze IVUS in
patients with increased volume of calcification. Therefore, we
excluded two patients with insufficient images from VH-
IVUS analysis. However, considering that there were only a
few studies to assess the detailed coronary plaque morphol-
ogy, especially in living CKD patients, we believe that our
study is potentially valuable in understanding the pathophy-
siology of CVD in CKD patients.
In conclusion, our findings suggested that the composi-
tional plaque pattern in coronary culprit lesion was
transformed from necrotic-rich plaques into calcium-rich
plaques with the development of CKD, and that its
composition was associated with its stability. In addition,
VH-IVUS was thought to be a useful device not only for
determining optimal strategies for coronary intervention but
also for understanding the pathophysiology of CVD in CKD.
MATERIALS AND METHODS
Study population and design
A total of 950 patients had undergone coronary angiography and
VH-IVUS between May 2005 and December 2009 at our institution.
Of these patients, 813 were excluded because they did not
have sufficient records of clinical laboratory examinations and/or
VH-IVUS for their evaluation. Forty-nine patients who had lesions
after coronary bypass grafting or percutaneous coronary interven-
tion were also excluded. Furthermore, patients with overt infection
(three patients), malignancy (five patients), and inflammatory
disease (two patients) were also excluded (Figure 6). The remaining
78 patients were included in this study. Of these patients, 23 were
also included in our previous study.11 The 78 study patients were
classified into four groups based on their eGFR (eGFRX60 (ml/min
per 1.73m2), n¼ 31; 30p eGFR o60, n¼ 24; eGFR o30, n¼ 11;
HD, n¼ 12).
For the diagnosis of CAD, AMI was defined as prolonged chest
pain with typical electrocardiographic changes and enzyme elevation
(creatine kinase (CK) or CK-MB 42 times the upper limit of the
normal range) within 24 h after the onset of symptoms.37 UAP was
defined as new-onset angina (within 2 months) or accelerated
angina (more severe, frequent, or longer in duration) or angina at
rest, whereas SAP was defined as typical chest pain on exertion.38
Diabetes mellitus was defined as a fasting blood glucose level
X126mg/dl or the use of antidiabetic medications (insulin or oral
hypoglycemics). Hypertension was defined as systolic blood pressure
X140mmHg, diastolic blood pressure X90mmHg, or the use of
antihypertensive drugs. Hyperlipidemia was defined as a present or
past low-density lipoprotein cholesterol levelX140mg/dl or the use
of statin. Experimental protocols were approved by the appropriate
institutional review committee, and informed consent was obtained
from all subjects.
VH-IVUS imaging and analysis
As described in our previous study,11 we analyzed the culprit lesion,
which was defined as one of the most stenotic lesions responsible for
clinical symptoms and results of examinations, such as echocardio-
graphic abnormalities and/or positive findings of stressed electro-
cardiogram and/or myocardial scintigraphy in this study. All
VH-IVUS examinations were performed before PCI and after intracor-
onary administration of 300mg nitroglycerin. VH-IVUS was not
performed when patients had lesions that were difficult to cross the
IVUS catheter. Furthermore, if the lesion showed angiographic signs
of thrombus, thrombus aspiration was performed to avoid incorrect
identification of a thrombus as a coronary plaque. The VH-IVUS
catheter was automatically pulled back at a rate of 0.5mm/s
throughout the culprit lesion. During pullback, all IVUS images
were recorded. We reviewed these images on a display, and the vessel
and lumen areas of each selected culprit lesion were traced for every
recorded frame. From these profiles, plaque composition was
analyzed using a custom-built software (Volcano Therapeutics,
Rancho Cordova, CA). Results were expressed as the relative and
absolute volumes of four major plaque components: fibrous, fibro
fatty, DC, and NC.
Using the results of the VH-IVUS analysis, the percentage of
plaque volume (% plaque volume) was calculated as follows: (total
plaque volume/vessel volume) 100 (%). Furthermore, we calcu-
lated the NC/DC ratio as %NC/%DC for assessment of plaque
transformation, which was based on the method described by Missel
et al.7 In each patient, the angle of the largest calcium deposit, which
was chosen in each assessed plaque area, was measured with a
protractor centered on the lumen, and it was defined as ‘maximal
arc of calcium deposit’ by reference to the method described in the
previous report.9 For assessment of reproducibility, inter-rater
reliability was measured by calculating the intraclass correlation
coefficient. The inter-observer intraclass correlation coefficient was
0.98 for three observers.
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Measurement of biomarker by clinical laboratory tests
Venous blood was collected from each patient following a 20-min
period of supine rest in the morning after overnight fasting. In the
HD group, blood was collected at the beginning of the first dialysis
session of each week according to the Japanese society of dialysis
therapy guideline. Laboratory tests were conducted according to
standardized clinical laboratory methods. The blood chemistry data
were calculated as the average of three measurements. To assess renal
function, we applied the following modified version of the Modifi-
cation of Diet in Renal Disease equation for evaluating Japanese
CKD patients:39 eGFR (ml/min per 1.73m2)¼ 0.741 175 (serum
creatinine, mg/dl)–1.154 (age, years)–0.203 (0.742 for women).
Statistical analysis
All statistical analyses were performed using StatView 5.0. for
windows (SAS Institute, Cary, NC). All values are expressed as
mean±s.d. A comparison of patient characteristics and IVUS analyses
between the groups was performed using the w2-test (for categorical
variables) and one-way analysis of variance (for continuous variables),
followed by the Games-Howell post hoc analysis. Univariate and
multivariate regression analyses were performed to assess the
contributors to the development of each plaque composition. Values
were described as mean±s.d., and Po0.05 was considered to be
statistically significant.
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